10pm Friday FRONTLINE OPIOIDS INC – Investigative series - The story of a drug company that pushed opioids by bribing doctors and committing insurance fraud. With the Financial Times, FRONTLINE investigates how Insys Therapeutics profited from a fentanyl-based painkiller 50 times stronger than heroin.
The rise of pharmaceutical company Insys Therapeutics and the federal prosecution that brought it down following charges of bribing doctors to prescribe a highly addictive opioid painkiller.
What role have pharmaceutical companies played in fueling America’s epidemic of opioid addiction? How have they and their stockholders profited? And how are they being held accountable?
The new FRONTLINE documentary Opioids, Inc., part of a yearlong reporting collaboration with the Financial Times, explores those questions through the story of one company: Insys Therapeutics.
The documentary reveals how Insys bribed doctors, committed insurance fraud and made millions for Wall Street investors pushing a highly addictive opioid painkiller called Subsys — and then, how it became the first pharmaceutical company to have its CEO sentenced to prison time in connection with the opioid crisis.
